Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...

Before August 20, Game Science's Black Myth: Wukong was a practically unknown project. 24 hours later, it was IGN's biggest news story of the day, had garnered over 10 million views on Chinese video ...

Bill Detwiler is the Editor for Technical Content and Ecosystem at Celonis. He is the former Editor in Chief of TechRepublic and previous host of TechRepublic's Dynamic Developer podcast and Cracking ...

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It ...